acetic acid [(3S,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[[(3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyl-2-oxanyl]oxy]-8-[[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyl-2-oxanyl]oxy]-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] ester

Term ID

CHEBI:95144

Synonyms

Definition

References

LINCS:LSM-6416

Ontology

ChEBI ( EBI )

Relationships

is a type of: aminoglycoside

aminoglycoside Show first 5 Terms

Phenotype

Phenotype resulting from acetic acid [(3S,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[[(3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyl-2-oxanyl]oxy]-8-[[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyl-2-oxanyl]oxy]-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] ester

Phenotype where environments contain acetic acid [(3S,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[[(3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyl-2-oxanyl]oxy]-8-[[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyl-2-oxanyl]oxy]-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] ester

Phenotype modified by environments containing acetic acid [(3S,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[[(3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyl-2-oxanyl]oxy]-8-[[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyl-2-oxanyl]oxy]-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] ester

Human Disease Model